Reports & Presentations

Financial statements are published on the company’s website in accordance with legislation in the United Kingdom governing the preparation and dissemination of financial statements, which may vary from legislation in other jurisdictions. The maintenance and integrity of the group’s website is the responsibility of the directors. The directors responsibility also extends to the ongoing integrity of the financial statements contained therein.

Q3 Results FY24

Q3 Results FY24

File NameReportPresentationAnalyst webcasts
Q3 Results FY24
Q1 FY24 Results
Annual Report FY23 (ESEF format)
Annual Report FY23
Q4 Results FY23
Full Year Results FY23
Q3 Results FY23
Interim and Q2 Results FY23
Q1 Results FY23
Annual Report FY22
Full Year Results
Q4 Results FY22
Capital Markets Day Presentation Sept 2022
Green Bond Second Party Opinion Sept 2022
Green Bond Framework Sept 2022
Q3 Results FY22
Interim and Q2 Results FY22
Q1 Results FY22
Full Year Results
Annual Report FY21
Q3 Results FY21
Trading update: Ectosan® Vet Marketing Authorisation July 2021
Interim and Q2 Results FY21
Q1 Results FY21
Annual Report FY20
Q4 Results FY20
Q3 Results FY20
Interim and Q2 Results FY20
Q1 Results FY20
Proactive Investors Presentation Jan 2020
Annual Report FY19
Trading Update Presentation Nov 2019
Q3 Update FY19
Interim and Q2 Results FY19
Preliminary Results Presentation FY18
Annual Report FY18
Interim and Q2 Results FY18
Capital Markets Day Presentation FY2018
Preliminary Results presentation FY17
Annual Report FY17
Interim Results FY17
Annual Report FY16
Berenberg European Conference 2016
Capital Markets Day Presentation Nov 2016
Equity Raise July 2016
Preliminary Results presentation FY16
Interim Results FY16
Annual Report FY15
Preliminary Results presentation FY15
Interim Results FY15
Annual Report FY14
Interim Results FY14
Interim and Q2 Results FY24
keyboard_arrow_up